Dr. Chapa’s OBGYN Clinical Pearls

Dr. Chapa’s Clinical Pearls

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

  1. 3d ago

    Beware “The Dolphin Sign” at Second Stage

    Welcome back to the show. Let’s take a quick step back in time. Think about how far we’ve come: we went from pressing a classic OB fetoscope up against a pregnant belly just to catch a faint, muffled thumping, to relying on advanced, continuous electronic monitoring. We live in an era of high-tech obstetrics. But even with all these modern advancements, room for error still exists, especially during the high-stakes chaos of the second stage of labor. In fact, this exact vulnerability was flagged as a critical warning in ACOG’s Clinical Practice Guideline Number 10. The issue? Relying on an external fetal heart rate Doppler that can silently mistake the maternal heart rate for the fetal heart rate. And now, a team of authors from New York writing in the AJOG are bringing even sharper focus to this danger, introducing a brand-new term for your clinical radar: "The Dolphin Sign." It’s a striking visual descriptor for a phenomenon born from maternal-fetal Doppler ambiguity—and if it goes unrecognized, it can leave a child at a devastating risk of acidosis. If you want to know how to spot it, what it means for your delivery room management, and how to protect your patients, you're going to want to stay tuned. PROMO CODE: https://aspiredrinks.com/discount/CHAPANOSPINOBG 1. ACOG CPG #10, October 2025 2. VINTZILEOS A, CHAVEZ M. The Dolphin Sign on fetal heart rate tracing: maternal-fetal signal ambiguity during the second stage of labor. American Journal of Obstetrics & Gynecology, 2026; 0 3. Kiely, D.J., Oppenheimer, L.W. & Dornan, J.C. Unrecognized maternal heart rate artefact in cases of perinatal mortality reported to the United States Food and Drug Administration from 2009 to 2019: a critical patient safety issue. BMC Pregnancy Childbirth 19, 501 (2019). https://doi.org/10.1186/s12884-019-2660-5

  2. 6d ago

    Severe BP Intrapartum, Non-severe on Repeat: PreE with Severe Nuances

    Now, if you’ve been in OB care for more than a month, you know that preeclampsia is one of those topics we talk about constantly. We have endless guidelines, algorithms, and diagnostic criteria plastered all over our unit walls. But here’s the truth: despite all the literature out there, the real world doesn't always read the textbook. The clinical nuances… The gray areas…That’s where things get tricky. Take a classic labor and delivery scenario: Your patient in active labor throws a blood pressure in the severe range. You follow protocol and get a repeat BP 15 minutes later—and it’s back down in the non-severe range. So, what now? Does that initial single severe reading still count toward a diagnosis of preeclampsia with severe features, or does severe range have to be sustained? And let’s make it even more interesting: What if later in the shift, she hits another severe-range BP, but again, it drops to non-severe on the 15-minute recheck- yet both of those spikes under that standard 4-hour window? Is that officially preeclampsia with severe features? That right there is the absolute peak of clinical nuance. It’s the difference between blindly following a chart and actually delivering sharp, nuanced bedside care. So, grab your coffee, settle in, and let's break down the details. ASPIREDRINKS.com PROMO CODE: https://aspiredrinks.com/discount/CHAPANOSPINOBG ​ ACOG PB 222​ Countouris ME, Bello NA. Advances in Our Understanding of Cardiovascular Diseases After Preeclampsia. Circ Res. 2025 Mar 14;136(6):583-593. doi: 10.1161/CIRCRESAHA.124.325581. Epub 2025 Mar 13. PMID: 40080539; PMCID: PMC11921930.

  3. Oct 31

    Maternal Fragile X Carrier: NEXT STEPS

    Today, we’re diving into a topic that has completely transformed prenatal care over the past decade—non-invasive prenatal testing, or NIPT. Thanks to recent technological leaps, cfDNA, cell-free fetal DNA, is giving us unprecedented visibility through just a simple maternal blood draw. Take Fetal Focus by Natera, for example, or the UNITY Reflex Screen from BillionToOne. These options offer single-gene NIPT that can evaluate fetal risk for specific autosomal recessive conditions, like cystic fibrosis, spinal muscular atrophy, or sickle cell disease, to better risk stratify the fetus without going immediately to an invasive diagnostic test. Similarly, The UNITY CONFIRM option also evaluates whether a fetus is at low or high risk for fetal aneuploidies—chromosomal conditions like Trisomy 21, 18, and 13 up to a set gestational age as an alternative to amniocentesis, although that is still considered a screening test. That specialized test uses intact circulating fetal cells to non-invasively help assess aneuploidy risk without an immediate invasive procedure. But what happens when the maternal carrier screen comes back positive for a complex genetic variant, specifically a Fragile X mutation (an FMR1 gene expansion)? Should that automatically trigger a referral for diagnostic testing? In this episode, we’re going to cover exactly how Fragile X inheritance works, why current non-invasive technologies hit a wall with repeat expansion disorders, and what clinical decision steps patients and providers need to take next. 1. Carrier Screening for Genetic Conditions; ACOG CO NUMBER 691. MARCH 2017 (REAFFIRMED 2025) 2. https://utswmed.org/medblog/fragile-x-syndrome-pregnancy/

  4. Oct 28

    Choline in Pregnancy: New Oct 2026 RCT

    Choline is not a nutrient that the human body can synthesize in sufficient quantities; it must be obtained from dietary sources (eggs, meat, fish, dairy products, grains, and nuts). Its a water-soluble amine that serves as a precursor for phospholipids, which are vital components of cell membranes. Plus, it’s a vital component of acetylcholine, a neurotransmitter involved in numerous brain functions. Inadequate choline intake during fetal organogenesis is associated with neural tube defects and cognitive deficits in offspring. In the mother, low choline use has been associated with preeclampsia, preterm birth and possible fetal growth restriction. While choline is crucial for fetal development and maternal outcomes, studies suggest that many pregnant women don’t meet the recommended dietary intake, potentially risking maternal and fetal health. ACOG recommends that pregnant women consume 450 mg of choline each day, although there is no universal internationally agreed upon dose for proper maternal supplementation. Of note, the current recommendations for pregnant women were set in 1998 and were based on the amount of choline needed to prevent liver dysfunction in men, not on the more relevant outcome of offspring neurocognitive development. In this episode, we will highlight a new RCT (Article in Press-AJOG; Oct 19, 2026) on Choline supplementation in pregnancy and early childhood behavioral and cognitive outcomes. While the results were promising, there are some limitations to this study. Listen in for details. 1. Jaiswal A, Dewani D, Reddy LS, Patel A. Choline Supplementation in Pregnancy: Current Evidence and Implications. Cureus. 2023 Nov 8;15(11):e48538. doi: 10.7759/cureus.48538. PMID: 38074049; PMCID: PMC10709661. 2. Hunter S, Hoffman M, Law A .Prenatal Maternal Phosphatidylcholine and Children’s Behavior and Cognition through 4 Years of Age: Randomized Clinical Trial. American Journal of Obstetrics & Gynecology, 2026; 3. Bahnfleth CL, Strupp BJ, Caudill MA, Canfield RL. Prenatal choline supplementation improves child sustained attention: A 7-year follow-up of a randomized controlled feeding trial. FASEB J. 2022 Jan;36(1):e22054. 4. Cai F, Young BK, Mccoy JA. Commercially Available Prenatal Vitamins Do Not Meet American College of Obstetricians and Gynecologists Nutritional Guidelines. Am J Perinatol. 2024 May;41(S 01):e2547-e2554.

4
out of 5
477 Ratings

About

Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.

You Might Also Like